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Help Us Help You! 
Is this newsletter helpful to you?  
What articles would you like to see?  
Please contact Bridget Konz at 
bkonz@idph.state.ia.us or  
1-800-831-6293 ext. 7. 





Registry Information  
System (IRIS)  
Enroll Today! 
 
Call the IRIS  
Help Desk at 
 1-800-374-3958  
for Enrollment Details or 
IRIS Questions. 
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Remember that December, January, even 
February is not too late to vaccinate 
against influenza! In the United States, 
localized outbreaks that indicate the start of 
seasonal influenza activity can occur as 
early as October. 
 However, in greater than 80% of influenza 
seasons since 1976, peak influenza activity 
(which is often close to the midpoint of 
influenza activity for the season) has not occurred 
until January or later, and in greater than 60% of 
seasons, the peak was in February or later.   
To avoid missed opportunities for vaccination, 
providers should offer vaccination during routine 
health-care visits or during hospitalizations 
whenever vaccine is available.  
Vaccination efforts should continue throughout 
the season since the duration of the influenza 
season varies and influenza may not appear in 
communities until February or March.  Providers 
should offer influenza vaccine routinely, and 
organized vaccination campaigns should continue 
throughout the influenza season, including after 
influenza activity has begun in the community.  
Vaccine administered in December or later, even 
if influenza activity has already 
begun, is likely to be beneficial in 
the majority of influenza seasons. 
The majority of adults will 
develop antibody protection 
against influenza virus infection 
within 2 weeks after vaccination.  
Children aged 6 months through 
8 years who have not been vaccinated previously 
or who were vaccinated for the first time during 
the previous season and received only 1 dose 
should receive 2 doses of vaccine.  
These children should receive their first dose as 
soon after vaccine becomes available, so both 
doses can be administered before the onset of 
influenza activity1.  
For questions regarding VFC flu vaccine supply 
and distribution, please contact Tina Patterson at 
1-800-831-6293, ext.4; or for medical flu 
questions, please contact Terri Thornton or 
Bridget Konz at 1-800-831-6293, ext. 1 and 7 
respectively.  1: MMWR 2007 Jul 13;56(RR06):1-54. 
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Updated Materials 
In November, 2007 the Iowa Immunization Program presented 
Vaccine University to over 500 participants across the state.   
The storage and handling binder that was provided as part of 
the training contains the Recommendations for Storage and 
Handling of Selected Biologicals published by the Centers for Disease Control and Prevention (CDC).  
This booklet outlines the details of storing and handling of all vaccines.  Information includes shipping re-
quirements, condition upon arrival, storage requirements, shelf life, instructions for use, shelf live after 
opening, and special instructions.   
In late November 2007, the CDC updated the Vaccine Management Book.  An updated copy of this 
publication can be found at the following CDC webpage: 
http://www.cdc.gov/nip/publications/vac_mgt_book.htm.  Continued on page 2 
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On September 19, 2007, the U.S. Food and 
Drug Administration (FDA) approved the ex-
panded use of FluMist (Influenza Virus Vac-
cine Live, Intranasal) in children two through 
four years of age.  FluMist is now approved 
for active immunization for the prevention of 
influenza disease in individuals 2 through 49 
years of age.   
 Prior to inclusion of these recommendations 
into the Vaccines for Children (VFC) Pro-
gram, federal law requires the Advisory Com-
mittee on Immunization Practices (ACIP) to 
pass resolutions that determine VFC Program 
vaccine availability and immunization sched-
ules.  
On October 26, 2007, the ACIP voted to in-
clude the new licensing for FluMist into the 
VFC Program.  This change allows VFC Pro-
gram providers can administer FluMist vac-
cine to eligible children, 2 through 18 years of 
age.   
FluMist Influenza Vaccine—Vaccines for Children Program 
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The changes, aside from general word/formatting edits, in the November Publication include: 
(1) TIV:  “Protect TIV (Fluiarix and FluLaval) from light at all times by storing in the original packages.” 
(2) LAIV”: “If LAIV is inadvertently frozen, the vaccines should be moved immediately to the refrigerator and may be 
used until the expiration date stated printed on the package.”  
(3) MMRV: “Do not store lyophilized vaccine in the refrigerator.  If lyophilized vaccine is inadvertently stored in the 
refrigerator, it should be used within 72 hours.  Lyophilized vaccine stored at 35°F-46°F which is not used within 
72 hours should be discarded.” 
(4) MPSV: “Multidose vials: Unused portions of multdose vials may be refrigerated at 35°F-46°F and used up to 35 
days after reconsitiution.” 
Vaccine University Updated Material (cont) 
 VFC Program Recommended LAIV (FluMist) Vaccine Schedule 
 Age Group Number of Doses 
 2 through 18 years of age 1 or 2* 
 *All children 2 through 8 years of age who receive LAIV (Flumist) influenza vaccine for 
the first time should be given two doses.  Children who receive only one dose in the first 
year of vaccination should receive two doses, rather then one, in their second year of 
vaccination. 
 
 Recommended LAIV (FluMist) Interval (2-8 years of age) 
Minimum Age Minimum interval dose 1 to 2 (when  
2 years 4 weeks 
 If you have questions regarding the above information or the administration of LAIV 
(FluMist) influenza vaccine please contact Terri Thornton or Bridget Konz at 1-800-831-
6293, ext. 1 and 7 respectively. 
Cold Weather Shipping Reminder 
Please remember that  vaccine orders will not be distributed during periods of extreme cold and snow.  When 
outside temperatures drop severely it is possible that even properly packaged vaccine may be exposed to tem-
peratures outside the recommended ranges during the shipping process.  If extreme weather prevents shipping, 
the Immunization Program will notify VFC providers by e-mail.    It is important to pay close attention to your 
vaccine inventory throughout the winter.   
Additionally, please remember to return coolers upon receipt of vaccine, using the enclosed postage paid label.  
If you have questions please contact Janean Iddings at 1-800-831-6293, ext. 5  
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Summary of Changes to the Adult Immunization 
Schedule for 2007-2008 
The Advisory Committee on Immunization 
Practices (ACIP) annually reviews the rec-
ommended Adult Immunization Schedule to 
ensure that the schedule reflects current 
recommendations for the licensed vaccines. 
In June 2007, ACIP approved the Adult Im-
munization Schedule for October 2007–
September 2008.  The key changes are 
highlighted below.  
 Age-Based Schedule  
• The yellow bar for varicella vaccine has 
been extended through all age groups, indi-
cating that the vaccine is recommended for 
all adults without evidence of immunity to 
varicella. 
• Zoster vaccine has been added, with a 
yellow bar indicating that the vaccine is rec-
ommended for persons aged >60 years.  
 Medical/Other Indications Schedule  
• The title has been changed to “Vaccines 
that might be indicated for adults based on 
medical and other indications,” indicating 
that not all of the vaccines are recom-
mended based on medical indications. 
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• The word “contraindicated” has been added 
to the red bars and removed from the legend. 
• The “immunocompromising conditions” col-
umn heading has been shortened by removing 
the list of conditions. 
• The “human immunodeficiency virus (HIV) 
infection” column has been moved next to the 
“immunocompromising conditions” column. 
• The HIV column has been split into CD4+ T 
lymphocyte counts of <200 cells/μL and >200 
cells/μL. 
• The indication “recipients of clotting factor 
concentrates” has been removed from the 
column heading “chronic liver disease” be-
cause only one vaccine has this recommenda-
tion. The indication remains in the hepatitis A 
vaccine footnote. 
• The varicella vaccine yellow bar has been 
extended to include persons infected with HIV 
who have CD4+ T lymphocyte counts of >200 
cells/μL (1). 
• The influenza vaccine yellow bar for “health-
care personnel” indicates that health-care 
personnel can receive either trivalent inacti-
vated influenza vaccine (TIV) or live, attenu-
ated influenza vaccine (LAIV). 
• The yellow bar for influenza vaccine has 
been extended to include persons in the 
“asplenia” risk group.  
• The bar for meningococcal vaccine has 
been revised to indicate that 1 or more doses 
might be indicated. 
• Zoster vaccine has been added to the 
schedule with a yellow bar to indicate that the 
vaccine is recommended for all indications 
except pregnancy, immunocompromising 
conditions, and HIV. A red bar, indicating a 
contraindication, has been inserted for preg-
nancy, immunocompromising conditions, and 
HIV infection with a CD4+ T lymphocyte 
count of <200 cells/μL. 
Several of the footnotes (numbers 
2,3,4,6,9,10, 11, 13) have been reworded or 
updated.  If you have question regarding 
vaccines or the Adult schedule, please con-
tact Terri Thornton or Bridget Konz at 1-800-
831-6293 (ext 2 and 7 respectively).  
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Surveillance of Vaccine-Preventable Diseases (original air date: December 13, 2007).  
This course is designed to provide information on case investigation, outbreak control, and disease reporting for vaccine-preventable diseases. 
The course will stress the most epidemiologically important data to collect and will discuss methods of enhancing surveillance and completing 
case investigations. The course text is the Manual for the Surveillance of Vaccine-Preventable Diseases. This manual is available online 
only at: http://www.cdc.gov/vaccines/pubs/surv-manual/default.htm.   
The broadcast will have a live Webcast, which will also be available through the Internet for 1 month following the broadcast and can be found 
at: http://www2a.cdc.gov/PHTN/webcast/VPD-07. This program will be edited and made available for self-study in DVD and web-on-demand 
formats 4 to 6 weeks after the broadcasts. The program will not be available as a videotape.  To order the DVD, use the online order form 
found at: http://www.cdc.gov/vaccines/pubs/default.htm.  
Continuing education credits will be provided. For more information, please log on to the National Center for Immunization and Respiratory 
Diseases and Public Health Training Network Satellite Broadcast & Webcast Program website:http://www2a.cdc.gov/PHTN/VPD-07 
Epidemiology and Prevention of Vaccine-Preventable Diseases Satellite Broadcast 
The satellite broadcast series Epidemiology and Prevention of Vaccine-Preventable Diseases has been presented at least once a year since 
1995. Due to escalating costs and limited availability of the CDC broadcast facility the series will no longer be presented as a live broadcast.  
Beginning in 2008 this training program will be available only on DVD and by internet. The 2008 series is expected to be available in late 
spring. Additional details will be forthcoming in future editions of the Immunization Works newsletter (located at: 
http://www.cdc.gov/vaccines/news/newsltrs/imwrks/)  
CDC Education Updates 
Adolescents generally seek 
recommended preventive 
health services less frequently 
than children in other age 
groups and often do not have 
an identified medical home, making it difficult 
for health care providers to promote vaccina-
tion.  Actively encouraging adolescents, teens 
between the ages of 11 and 19, to be vacci-
nated is a new focus of the CDC and the Iowa 
Immunization Program. 
 The CDC is trying to draw providers and 
parents focus to the importance of adolescent 
vaccinations by dividing the recommended 
childhood and adolescent immunization 
schedule into two schedules: one for children 
from birth to six years of age and a second for 
those seven to 18 years of age, with ages 11-
12 recommended for most vaccines. "These 
new schedules reflect the great strides we are 
making to protect children and adolescents 
against serious diseases, including cancer," 
said Dr. Anne Schuchat, director of the Cen-
ters for Disease Control and Prevention's 
National Center for Immunization and Respi-
ratory Diseases. "We are providing a sepa-
rate schedule for those seven to 18 years of 
age because of an increasing number of 
vaccines being developed to protect adoles-
cents against disease." 
 The CDC and the ACIP have recommended 
three vaccines to be administered to adoles-
cents at the emerging 11-12 year-old  
“adolescent platform visit.” These vaccines 
include MCV4, which protects against menin-
gitis and its complications; Tdap, which is a 
booster against tetanus, diphtheria, and per-
tussis or “whooping cough,” and for females, 
the HPV (Human Papillomavirus) vaccine, 
which protects against the types of HPV that 
most commonly cause cervical cancer.   
Infant and early childhood 
immunization programs have 
grown over the years, which 
have resulted in record high 
immunization rates.  The Iowa 
Immunization Program is working to build 
and adolescent immunization program that 
is consistent with the success of the infant 
program.   To assist providers in educating 
clients, both adolescents and their parents, 
about the importance of vaccination, the 
CDC launched a preteen vaccine cam-
paign in August 2007.  The campaign ma-
terials, including posters and flyers in Eng-
lish and Spanish, are available at the CDC 
Web site: www.cdc.gov/vaccines/spec-
grps/preteens-adol.htm. 
If you have questions regarding the Ado-
lescent Immunization Program please con-
tact Kelly Rooney-Kozak at 1-800-831-
6293, ext 9. 






In previous newsletters we shared Iowa’s 
plans to transition to the Vaccine Manage-
ment Business Improvement Project 
(VMBIP) in December.  As part of this plan,  
vaccine in the United States will be shipped 
from a central location, McKesson General 
Medical in Memphis, TN.   
IDPH Immunization Program has been 
notified that VMBIP will be delayed until the 
March 2008. This delay will allow McKes-
son to complete distribution of influenza 
products for the states that have already 
transitioned to VMBIP.  In preparation for 
VMBIP, Iowa has been scaling back vac-
cine inventory.   
Since IDPH has less inventory on hand, it 
is imperative that we work together to en-
sure that clinics have sufficient vaccine 
available. 
Prior to implementing VMBIP in Iowa, the 
Immunization Program will be working with 
VFC program providers regarding vaccine 
ordering schedules and to assess vaccine 
storage capacity.   
Provider’s vaccine ordering schedule will be 
driven by tiered ordering frequency (TOF).  
TOF refers to establishing vaccine ordering 
schedule by identifying the number of or-
ders providers should place each year.  
Transitioning to a monthly, bi-monthly, or 
quarterly ordering allows IDPH to standard-
ize clinic ordering frequency. TOF will be 
based on provider ordering volume and 
IDPH will work with provider to establish an 
ordering cycle.    
In addition to vaccine ordering schedules, 
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the Iowa VFC Program will be conducting a 
survey to determine provider storage capacity.  
The survey will also request office hours to 
verify when vaccine can be shipped and when 
the office will be open to receive vaccine ship-
ments. 
VFC providers will not see a noticeable differ-
ence in the program and will continue to order 
vaccine either through IRIS or by paper copy.  
Providers are still required to be accountable 
for vaccine that has been administered and 
should ensure that doses are entered into IRIS 
or accounted for on the Monthly Doses Admin-
istered Report.  IDPH will continue to share 
progress and updates regarding the transition 
to VMBIP. 
For questions regarding vaccine distribution, 
please contact Tina Patterson at 1-800-831-
6293, ext. 5. 
 





The view-only version of IRIS, called the 
Immunization Registry Information Sys-
tem – Certificate Search (IRIS-CS), is 
now available.   
IRIS-CS allows schools to search, view 
and print the Certificate of Immunization. 
Using IRIS-CS will provide schools with 
required immunization information without 
added work on behalf of school personnel, 
parents, and health care providers.  
 Enroll today! Visit the IRIS Web site to 
obtain the IRIS-CS enrollment form, com-
puter requirements, and frequently asked 
questions about IRIS-CS at 
www.idph.state.ia.us/adper/immunization_
programs.asp#iris.   
For IRIS-CS questions, please call the 
IRIS Help Desk at 1-800-374-3958. 
Welcome!  
The Immunization Program is happy to 
announce that Kelly Rooney-Kozac has 
joined our program as the Adolescent Coor-
dinator. Kelly comes to the Immunization 
Program from the US Peace Corps where 
she worked primarily in HIV/AIDS education 
in the Ukraine.   
We are also happy to announce that Kelly 
and her husband, Roman, welcomed into 
their family a baby boy on November 29, 
2007.  We are excited to have her join our 




but when she 
returns she 
can be 
reached at (515) 281-0916, or 1-800-831-
6293, ext 8 or by email at: 
krooney@idph.state.ia.us.   
Want to receive the  
Immunization Update  
Newsletter at your desk?   
Do you know someone who would?  Send 
your name, or theirs,  and mailing address to 
Bkonz@idph.state.ia.us and we will sign you 
up—it’s as easy as that!  The Immunization 
Update is also available on our Web page at: 
www.idph.state.ia.us/adper/immunization.asp 
It’s a great way to send the Newsletter on to 
others in your facility or community.   
 
Comments?  
We would love to hear 
what you think of the 
newsletter, or if there are topics you would like 
us to cover.  Please email Bridget at the email 
address above.   
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 PedvaxHIB Vaccine Availability
The Iowa Department of Public Health Im-
munization Program has received notifica-
tion from the CDC (CDC) that the supply of 
haemophilus influenzae B vaccine (Hib) 
PedvaxHIB manufactured by Merck, is cur-
rently unavailable, or in a limited quantities, 
due to a manufacturing issue.   
At this time, Merck is unable to provide infor-
mation on how long PedvaxHIB will be un-
available.  Supply is expected to improve 
within the first quarter of 2008.  
The Immunization Program will fill Hib vac-
cine orders with ActHIB manufactured by 
sanofi pasteur.  The Immunization Program 
will continue to review all Hib vaccine orders 
to assure all providers receive Hib vaccine.  
It is anticipated that the supply of ActHIB 
vaccine is sufficient to fulfill Hib vaccine 
demand during the unavailability of Pedvax-
Hib.   
All brands of Hib vaccine are interchange-
able within their respective series.  If brands 
are changed during the vaccine series, a 
3 dose primary series is required (2, 4, 6 
months of age) with a booster (12-15 
months of age).  After completing the 
primary series, any Hib conjugate vac-
cine can be used for the booster dose at 
12-15 months of age. 
If you have questions regarding vaccine 
availability please contact Janean at 1-800-
831-6293, ext. 5, or for vaccine questions 
please contact Terri Thornton at 1-800-831-
6293, ext 2.  
Useful Web Sites for  
Immunization Providers 
 
Centers for Disease Control and Prevention  
National Immunization Program    
www.cdc.gov/nip   
 
Iowa Immunization Program 
www.idph.state.ia.us/adper/immunization.asp 
 
The Immunization Action Coalition  
www.immunize.org  
 
Children’s Hospital of Philadelphia    
www.vaccine.chop.edu  
 
American Academy of Pediatrics   
www.aap.org  
 
Every Child By Two 
www.ecbt.org 
 
Food and Drug Administration - Vaccines 
www.fda.gov/cber/vaccines.htm 
 
Hib Vaccine Schedule 
ActHIB (sanofi pasteur):  3 dose primary se-
ries (2, 4, 6 months of age) with a booster (12-
15 months of age) 
 
PedvaxHIB (Merck):  2 dose primary series 
(2, 4 months of age) with a booster (12-15 
months of age) 
Ordering Immunization Print 
Materials On Line! 
The Immunization Program has updated our Web page to include on line 
ordering of all our printed materials.  All brochures, posters, and printed 
documents can be accesses to preview, print single copies, or order multi-
ple copies for your clinic.   
Remember that all our printed materials are offered at no cost to your 
clinic.  Our Web page address is:  
www.idph.state.ia.us/adper/common/pdf/immunization/literature_order_for
m.pdf.   
Materials can still be ordered by phone, fax, and email and general mail.  
Online ordering is the most recent addition to providing you cost effective, 
quality print materials.  
Call Toll Free 1-888-398-9696, fax your order form to (319) 861-2869, 
email clrhouse@crlibrary.org, or mail 
the order form (which may be found on 
our Web page) to:  
Health Protection Clearinghouse 
615 5th Street SE 
Cedar Rapids, IA 52401  
 
